IDEXX Laboratories Statistics

Total Valuation

IDEXX Laboratories has a market cap or net worth of GBP 28.63 billion. The enterprise value is 29.19 billion.

Market Cap	28.63B
Enterprise Value	29.19B

Important Dates

The next estimated earnings date is Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	80.99M

Valuation Ratios

The trailing PE ratio is 44.30.

PE Ratio	44.30
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	34.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.96, with an EV/FCF ratio of 49.36.

EV / Earnings	45.16
EV / Sales	9.35
EV / EBITDA	26.96
EV / EBIT	30.63
EV / FCF	49.36

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.62.

Current Ratio	1.42
Quick Ratio	0.89
Debt / Equity	0.62
Debt / EBITDA	0.75
Debt / FCF	1.26
Interest Coverage	35.59

Financial Efficiency

Return on equity (ROE) is 59.42% and return on invested capital (ROIC) is 29.02%.

Return on Equity (ROE)	59.42%
Return on Assets (ROA)	22.79%
Return on Capital (ROIC)	29.02%
Revenue Per Employee	260,783
Profits Per Employee	58,755
Employee Count	11,000
Asset Turnover	1.19
Inventory Turnover	3.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.33% in the last 52 weeks. The beta is 1.36, so IDEXX Laboratories's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	-17.33%
50-Day Moving Average	425.19
200-Day Moving Average	471.21
Relative Strength Index (RSI)	56.79
Average Volume (20 Days)	377

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.32

Income Statement

In the last 12 months, IDEXX Laboratories had revenue of GBP 2.87 billion and earned 646.30 million in profits. Earnings per share was 7.73.

Revenue	2.87B
Gross Profit	1.74B
Operating Income	875.51M
Pretax Income	815.57M
Net Income	646.30M
EBITDA	969.50M
EBIT	875.51M
Earnings Per Share (EPS)	7.73

Full Income Statement

Balance Sheet

The company has 230.27 million in cash and 744.82 million in debt, giving a net cash position of -514.54 million.

Cash & Cash Equivalents	230.27M
Total Debt	744.82M
Net Cash	-514.54M
Net Cash Per Share	n/a
Equity (Book Value)	1.21B
Book Value Per Share	14.72
Working Capital	316.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 684.04 million and capital expenditures -92.68 million, giving a free cash flow of 591.36 million.

Operating Cash Flow	684.04M
Capital Expenditures	-92.68M
Free Cash Flow	591.36M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.72%, with operating and profit margins of 30.52% and 22.53%.

Gross Margin	60.72%
Operating Margin	30.52%
Pretax Margin	28.43%
Profit Margin	22.53%
EBITDA Margin	33.80%
EBIT Margin	30.52%
FCF Margin	20.61%

Dividends & Yields

IDEXX Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.42%
Shareholder Yield	0.42%
Earnings Yield	2.26%
FCF Yield	2.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDEXX Laboratories has an Altman Z-Score of 18.95.

Altman Z-Score	18.95
Piotroski F-Score	n/a